Skip to main content
. 2016 Jul 1;6:28910. doi: 10.1038/srep28910

Figure 4. Overall Survival (OS) and Progression Free Survival determination in prostate cancer patients.

Figure 4

(A) OS durations in CTC+ patients with prostate cancer. (B) PFS durations in CTC+ patients with prostate cancer. (C) OS durations in nPDL-1+/CTC+ patients with prostate cancer. (D) PFS durations in nPDL-1+/CTC+ patients with prostate cancer.